High serum levels of CXCL13 predict lower response to csDMARDs in both ACPA-positive and ACPA-negative early rheumatoid arthritis
Year: 2024
Type: article
Study design: Observational Study
Source: Lara D. Veeken
Institutions: University of Pavia, Policlinico San Matteo Fondazione
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Awards: G1516707788, G8655108416
OpenAlex ID: W4403848575
